Insider · CIK 0002096714
Damien Alan Perriman
Files at EXOZ (EXOZYMES INC.). First filing -, latest -.
In brief
Damien Alan Perriman files SEC Form 4 as officer at EXOZ (EXOZYMES INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Damien Alan Perriman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | EXOZ EXOZYMES INC. | MOption exercise Common Stock | +19,612 | - | - | 28,499 | Aug 25, 2026 |
| Aug 19, 2026 | EXOZ EXOZYMES INC. | MOption exercise Restricted Stock Unitderivative | -19,612 | $0.00 | $0 | 43,147 | Aug 25, 2026 |
| Apr 1, 2026 | EXOZ EXOZYMES INC. | AGrant or award COMMON STOCK | +8,887 | $8.44 | $75k | 0 | Apr 8, 2026 |
| Apr 1, 2026 | EXOZ EXOZYMES INC. | AGrant or award Restricted Stock Grant for Common Stock | +62,759 | $0.00 | $0 | 62,759 | Apr 8, 2026 |
| Apr 1, 2026 | EXOZ EXOZYMES INC. | AGrant or award Stock Option for Common Stockderivative | +146,437 | $0.00 | $0 | 146,437 | Apr 8, 2026 |
Questions about Damien Alan Perriman
Answered from the filings on this page, as of the latest one.
Is Damien Alan Perriman buying or selling?
Damien Alan Perriman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Damien Alan Perriman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Damien Alan Perriman has 0.
Where does Damien Alan Perriman file Form 4?
Damien Alan Perriman has filed Form 4 at EXOZ (EXOZYMES INC.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.